The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Small Volume Parenteral Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The small volume parenteral market has experienced robust expansion over recent years. Its projected growth will take it from $191.36 billion in 2025 to $207.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Factors contributing to its historical growth include the increased adoption of injectable therapies, broader hospital-based drug administration, the availability of glass ampule packaging, a rise in acute care treatments, and the growing need for parenteral nutrition.
The small volume parenteral market is anticipated to experience substantial growth in the upcoming years, with its size projected to reach $275.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This expected expansion during the forecast period is primarily driven by factors such as escalating demand for biologics and vaccines, the increasing adoption of self-injectable therapies, an enlargement of aseptic manufacturing capacity, a heightened emphasis on advanced drug delivery systems, and amplified investments in sterile packaging technologies. Key trends throughout this forecast timeframe include the growing preference for prefilled syringe formats, a rising requirement for sterile injectable drugs, wider utilization of single-dose parenterals, an expansion in the administration of vaccines and biologics, and an intensified commitment to ensuring drug safety and stability.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15925&type=smp
What Drivers Are Influencing The Small Volume Parenteral Market?
The small-volume parenteral market is expected to grow as the number of surgeries increases. Surgery is a medical discipline that uses operative methods to examine or treat pathological conditions like disease or injury, enhance bodily function or appearance, or mend undesirable ruptured areas. The incidence of surgeries is rising due to advancements in medical technology and an aging demographic, which elevates the demand for surgical interventions. Small-volume parenteral solutions are utilized during surgeries to accurately deliver medications, electrolytes, and nutrients straight into the bloodstream. For instance, in June 2024, data from the American Society of Plastic Surgeons, a US-based non-profit organization, showed that minimally invasive procedures grew by 7% in 2023, exceeding the growth rate of surgical procedures by 2%. Hand surgeries, such as those for carpal tunnel, arthritis, and trigger finger, amounted to 207,887 procedures, marking a 2% increase from 2022. Therefore, the expanding number of surgeries is propelling the growth of the small-volume parenteral market.
What Major Segment Divisions Exist Within The Small Volume Parenteral Market?
The small volume parenteral market covered in this report is segmented –
1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorders, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users
Subsegments:
1) By Ampules: Glass Ampules, Plastic Ampules
2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials
3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes
How Are Trends Shaping The Direction Of The Small Volume Parenteral Market?
Major companies engaged in the small-volume parenteral market are directing their efforts toward creating advanced solutions, including prefilled, ready-to-use injectable formulations. These innovations are designed to improve dosing accuracy, reduce the risk of contamination, and enhance patient safety. Prefilled, ready-to-use injectable formulations are medical preparations already measured within a sterile syringe or vial, enabling direct administration by healthcare providers without requiring additional preparation. An example of this trend occurred in June 2025, when Gland Pharma Limited, an India-based generic injectable-focused pharmaceutical company, obtained approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Angiotensin II Acetate Injection 2.5 mg/mL. This injection is prescribed for rapidly elevating blood pressure in adults suffering from septic or distributive shock when standard therapies are inadequate. It operates by binding to vascular smooth muscle receptors, which triggers vasoconstriction and stimulates aldosterone release, with a quick onset that generally achieves target blood pressure within five minutes. Administered intravenously, the dose is precisely titrated to maintain the desired blood pressure, offering vital support for patients who remain hypotensive despite receiving fluid resuscitation and vasopressor therapy.
Which Companies Are Leading Innovation In The Small Volume Parenteral Market?
Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc, Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.
Read the full small volume parenteral market report here:
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Small Volume Parenteral Market?
North America was the largest region in the small volume parenteral market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Small Volume Parenteral Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15925&type=smp
Browse Through More Reports Similar to the Global Small Volume Parenteral Market 2026, By The Business Research Company
Parenteral Nutrition Market Report 2026
https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report
Small Volume Parenteral Market Report 2026
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Large Volume Parenteral Lvp Market Report 2026
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model